<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jackson</surname>
    <given-names>L. A.</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>E. J.</given-names>
   </name>
   <name>
    <surname>Rouphael</surname>
    <given-names>N. G.</given-names>
   </name>
   <name>
    <surname>Roberts</surname>
    <given-names>P. C.</given-names>
   </name>
   <name>
    <surname>Makhene</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Coler</surname>
    <given-names>R. N.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2020</year>). 
  <article-title>An mRNA Vaccine against SARS-CoV-2 — Preliminary Report.</article-title>
  <source>
   <italic>N. Engl. J. Med.</italic>
  </source>
  <volume>383</volume>
  <fpage>1920</fpage>–
  <lpage>1931</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa2022483</pub-id>
  <?supplied-pmid 32663912?>
  <pub-id pub-id-type="pmid">32663912</pub-id>
 </mixed-citation>
</ref>
